IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#698
Positioning
Market Dominance
Manufacturing
Medical Equipment
$9.1B
Joseph M. Hogan
Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Alignmenter segment consists of comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption. The Scanners & Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthmodontic procedures.
Headcount
23.2K
HQ Base
San Jose, Arizona
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = ALGN ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$UL UNILEVER PLC | 78 | 96 | 98 | 59 | - | - | 28.5% | 8.0% | 100.0% | 100.0% | 10.4% | -4.6% | 3.3% | 0.0x | $141.8B | VS | |
$ASML ASML HOLDING NV | 77 | 89 | 86 | 83 | - | - | 46.1% | 16.6% | 51.3% | 31.9% | 26.8% | -4.0% | 1.0% | 25.0x | $272.1B | VS | |
$ESLT ELBIT SYSTEMS LTD | 76 | 81 | 87 | 85 | - | - | 10.3% | 3.1% | 24.1% | 7.2% | 4.7% | 14.3% | 0.8% | 25.0x | $11.4B | VS | |
$MT ArcelorMittal | 75 | 71 | 98 | 85 | - | - | 2.2% | 1.5% | 9.3% | 5.3% | 2.2% | -8.5% | 2.2% | 16.0x | $18.9B | VS | |
$AMAT APPLIED MATERIALS INC /DE | 75 | 85 | 87 | 84 | 20.9x | 13.6x | 35.5% | 19.8% | 48.7% | 29.2% | 24.7% | 4.4% | 0.8% | 32.0x | $181.9B | VS | |
$SIMO Silicon Motion Technology CORP | 75 | 84 | 86 | 85 | - | - | 11.8% | 8.8% | 45.9% | 11.3% | 11.1% | 25.7% | 3.7% | 0.0x | $1.8B | VS | |
$CODA Coda Octopus Group, Inc. | 74 | 83 | 90 | 79 | 16.3x | 11.9x | 7.6% | 7.0% | 66.5% | 17.1% | 15.6% | 39.0% | 0.0% | 0.0x | $115M | VS | |
$GSK GSK plc | 74 | 84 | 90 | 70 | - | - | 22.6% | 4.9% | 71.2% | 12.8% | 9.4% | 1.7% | 5.9% | 124.0x | $72.1B | VS | |
$EFXT Enerflex Ltd. | 74 | 80 | 91 | 83 | - | - | 3.0% | 1.1% | 20.9% | 7.3% | 1.3% | 3.0% | 0.9% | 67.0x | $1.2B | VS | |
$BUD Anheuser-Busch InBev SA/NV | 74 | 84 | 97 | 63 | - | - | 8.2% | 3.5% | 55.3% | 25.9% | 12.4% | 0.7% | 1.7% | 0.0x | $87.0B | VS | |
$ALGN ALIGN TECHNOLOGY INC | 60 | 66 | 68 | 52 | 34.9x | 24.7x | 9.9% | 6.3% | 68.3% | 13.9% | 9.8% | -3.2% | 0.0% | 58.0x | $9.1B | ||
| SECTOR BENCH | - | - | - | - | - | 22.3x | 11.5x | -2.5% | -0.1% | 42.5% | 1.3% | -0.2% | 5.9% | 0.0% | 0.2x | - | REF |
ALIGN TECHNOLOGY INC (ALGN) receives a "Hold" rating with a composite score of 59.9/100. It ranks #698 out of 7,333 stocks in our coverage universe and carries a 3-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Joseph M. Hogan
Chief Executive Officer
Labor Force
23,200
66
45
56
Audit Verdict: Average governance indicators based on financial metrics.
No recent insider transactions available for ALGN
In-line with peers — no strong momentum signal
Trading at a discount to fundamentals — favorable entry valuation
High profitability & efficiency — strong quality floor supports entry
Average volatility — neutral timing signal
Moderate investment profile
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Manufacturing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
Projection based on user-defined inputs. Re-calculated daily against current market data.
Reverse DCF Framework — Mauboussin Methodology
Institutional-grade Reverse DCF analysis. This model identifies the growth hurdles embedded in current market prices. When implied growth is significantly lower than historical or projected rates, a margin of safety may exist. Re-audited daily.
No analyst ratings for ALGN.
View All RatingsNet income exceeding cash flow (Accrual bloat detected)
Material decline in asset turnover efficiency detected
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 66 | 70 | -4NEUTRAL |
| MOMENTUM | 52 | 40 | +12ALPHA |
| VALUATION | 68 | 60 | +8ALPHA |
| INVESTMENT | 45 | 84 | -39DRAG |
| STABILITY | 56 | 43 | +13ALPHA |
| SHORT INT | 58 | 67 | -9DRAG |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROE proxy 9.9% (sector -2.5%)
GM 68% vs sector 43%, OM 14% vs sector 1%
Capital turnover N/A, R&D intensity 9.6%
Rev growth -3%, 10yr history
Interest coverage N/A, Net debt/EBITDA -10.4x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Our model assigns ALIGN TECHNOLOGY INC a Hold rating, with a composite score of 59.9/100 and 3 out of 5 stars. Ranked #698 of 7,333 stocks, ALGN presents a mixed quantitative picture — neither compelling enough to initiate new positions nor weak enough to warrant selling. Investors already holding may consider maintaining their position while monitoring for changes in the factor profile.
ALGN earns a quality score of 66/100, indicating above-average business quality. The company reports a return on equity of 9.9% (sector avg: -2.5%), gross margins of 68.3% (sector avg: 42.5%), net margins of 9.8% (sector avg: -0.2%). Companies in this tier generally demonstrate consistent profitability and efficient capital deployment, though they may face some competitive pressure.
ALGN's value score of 68/100 indicates the stock is fairly valued based on its current fundamentals. Key valuation metrics include a P/E ratio of 34.91x, an EV/EBITDA of 24.67x, a P/B ratio of 3.45x. At this level, neither a clear bargain nor overpriced, the stock's attractiveness depends more on forward growth expectations and qualitative factors.
With an investment score of 45/100, ALGN exhibits moderate growth-oriented spending. Key growth metrics include revenue growth of -3.2% vs. a sector average of 5.9% and a return on assets of 6.3% (sector: -0.1%). The company appears to be balancing growth investments with capital returns, though the pace of investment may not be enough to accelerate top-line growth meaningfully.
ALGN demonstrates moderate momentum with a score of 52/100, suggesting a neutral price trend without strong directional conviction. Revenue growth stands at -3.2% year-over-year, while a beta of 1.26 reflects its sensitivity to broader market moves. Moderate momentum may indicate the stock is consolidating or transitioning between trends, warranting close monitoring of upcoming catalysts.
With a stability score of 56/100, ALGN exhibits average financial resilience. Key stability metrics include a beta of 1.26 and a debt-to-equity ratio of 58.00x (sector avg: 0.2x). While the balance sheet is not a major concern, the stock is subject to typical market volatility and may experience sharper drawdowns during risk-off episodes.
The short interest score of 58/100 for ALGN suggests somewhat elevated bearish positioning by institutional traders. Specific risk factors include above-average market sensitivity (beta: 1.26), elevated leverage (D/E: 58.00x). With a $9.1B market cap (mid-cap), ALIGN TECHNOLOGY INC may experience above-average volatility. Investors should consider whether the short thesis has merit or if it creates a potential short-squeeze opportunity.
ALIGN TECHNOLOGY INC is a mid-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #698 of 7,333 overall (90th percentile). Key comparisons include ROE of 9.9% exceeding the -2.5% sector median and operating margins of 13.9% above the 1.3% sector average. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.
While ALGN currently exhibits a HOLD profile, superior opportunities exist within the MANUFACTURING sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Manufacturing Alpha →Quant Factor Profile
Upgrade catalyst
Investment (45) is the limiting factor — improvement here would lift the composite score most.
EV/EBITDA 115% ABOVE SECTOR MEDIAN
ROE 498% BELOW SECTOR MEDIAN
Gross Margin 61% ABOVE SECTOR MEDIAN (FAVORABLE)
AUDIT DATA AS OF SEP 30, 2025 (Q2 FY2025)
We rate ALIGN TECHNOLOGY INC (ALGN) as a Hold with a composite score of 59.9/100 at a current price of $185.53. The stock presents a mixed quantitative picture — neither compelling enough to warrant new accumulation nor weak enough to justify selling for existing holders. Our factors are split, and the overall profile suggests patience is warranted.
The rating is primarily driven by strength in value (68th percentile) and quality (66th percentile), which together account for the majority of the composite score. All factors score above the 40th percentile, indicating no material weakness in the quantitative profile. We assign a Narrow Moat rating (48/100), Medium uncertainty, and Poor capital allocation.
Key items to watch: quarterly earnings execution and sector-level competitive dynamics. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
ALIGN TECHNOLOGY INC holds a top-quartile position (#0 of 50) within the Manufacturing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 59.9/100 places it at rank #698 in our full 7,333-stock universe. At $9.1B in market capitalization, ALIGN TECHNOLOGY INC is a mid-cap player in the Manufacturing space, which limits certain scale advantages but may allow for more agile strategic execution.
Revenue contraction of -3% combined with momentum at the 52th percentile paints a cautious picture of the near-term business outlook. The market appears to be pricing in continued challenges, and a catalyst for reversal is not clearly visible from current data.
The margin cascade tells an important story: gross margins of 68% (+25.8pp vs sector) narrow to operating margins of 14% (+12.6pp vs sector) and net margins of 9.8%, yielding a gross-to-net conversion rate of 14%. The significant margin erosion from gross to net suggests elevated operating expenses, high interest costs, or other structural drags that warrant monitoring.
At a current price of $185.53, ALIGN TECHNOLOGY INC is trading near fair value based on current fundamentals. Our value factor score of 68/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. Valuation metrics are mixed, with no strong signal of mispricing in either direction.
The stock currently trades at a P/E of 34.9x (a 57% premium to the sector median of 22.3x), EV/EBITDA of 24.7x (at a premium), P/B of 3.5x, P/S of 3.4x. The above-sector P/E multiple suggests the market is pricing in superior growth or quality, which our analysis partially supports given strong quality metrics.
Gross margins of 68% signal strong pricing power and brand/IP advantages — businesses with margins above 40% have historically demonstrated more resilient earnings through economic cycles.
A value factor score of 68/100 suggests the market is underpricing these fundamentals, creating a potential margin of safety for new investors.
Revenue decline of -3% signals business deterioration — declining revenues make it difficult to grow into the current valuation and often precede further negative revisions.
We assign a Medium uncertainty rating to ALIGN TECHNOLOGY INC. The stock presents a balanced risk profile: risk factors are within normal ranges. While not risk-free, the core business fundamentals are adequate to withstand moderate economic stress, and the range of potential outcomes around our fair value estimate is manageable.
We identify no major risk factors at this time. The company's stability factor sits at the 56th percentile with quality at the 66th percentile, both of which support our low-risk assessment. The absence of material leverage, profitability, or volatility concerns reduces the likelihood of a permanent capital loss scenario.
Key risk mitigants include: healthy gross margins of 68% provide a buffer against cost pressures. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile is favorable for long-term investors.
We rate ALIGN TECHNOLOGY INC's capital allocation as Poor. Key concerns include suboptimal returns on capital. Exemplary capital allocators generate ROE above 20% and maintain conservative leverage — ALIGN TECHNOLOGY INC significantly underperforms these benchmarks, raising questions about management's ability to create shareholder value.
Investors should scrutinize management's reinvestment decisions and balance sheet trajectory before committing capital. Poor capital allocation often compounds over time: overlevered balance sheets limit strategic flexibility, while low returns on capital destroy shareholder value. We would need to see sustained improvement in profitability metrics and balance sheet discipline before considering an upgrade.
In summary, ALIGN TECHNOLOGY INC receives a Hold rating with a composite score of 59.9/100 (rank #698 of 7,333). Our quantitative framework assigns a Narrow Moat (48/100, trend: stable), Medium uncertainty, and Poor capital allocation. The average factor score across quality, value, momentum, stability, and investment is 57/100.
Our analysis supports a neutral stance on ALIGN TECHNOLOGY INC. While the quantitative profile is not weak enough to warrant selling, it lacks the multi-factor strength required for a buy recommendation. Existing holders should maintain positions and monitor for catalysts — either fundamental improvement or valuation compression — that would shift the risk-reward balance.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We assign ALIGN TECHNOLOGY INC a Narrow Moat rating with a composite moat score of 48/100. The company possesses identifiable competitive advantages, though they are less entrenched than those of wide-moat peers. Our analysis indicates that ALIGN TECHNOLOGY INC can sustain above-average returns on invested capital for at least 10 years, with the strongest contributor being margin superiority at 18/20.
The strongest moat sources are margin superiority (18/20) and financial resilience (12/20). GM 68% vs sector 43%, OM 14% vs sector 1%. Interest coverage N/A, Net debt/EBITDA -10.4x. These pillars form the core of ALIGN TECHNOLOGY INC's competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include reinvestment efficiency (3.4/20) and economic value creation (4.9/20). Capital turnover N/A, R&D intensity 9.6%. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect ALIGN TECHNOLOGY INC's moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include gross margins of 68% providing a solid profitability foundation, operating margins of 14% reflecting effective cost management, declining revenues (-3%) that pressure the earnings outlook. The margin cascade from 68% gross to 14% operating to 9.8% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that the profit engine is high-quality and likely sustainable, with the quality factor at the 66th percentile.
The margin profile shows gross margins of 68%, operating margins of 14%, net margins of 9.8%. Return metrics include ROE of 9.9% and ROA of 6.3%. Relative to the Manufacturing sector, gross margins are 25.8 percentage points above the sector median of 43%, and ROE of 9.9% compares to a sector median of -2.5%.
The balance sheet reflects moderate leverage with D/E of 58%, revenue growth of -3%. The sector median D/E is 0%, putting ALIGN TECHNOLOGY INC at higher leverage than the typical peer. Overall balance sheet health is adequate for the current business environment.
Above 50MA
37.18%
Net New Highs
+51081
The Orthodontics Market is set for substantial growth, from US$7.68 billion in 2025 to US$20.88 billion by 2033, at a CAGR of 13.32%. Key drivers are technological advancements like digital scanning, AI treatment planning, and 3D printing, enhancing customization and accuracy. Orthodontics, addressing dental misalignments, has surged due to rising dental health awareness and aesthetic interests. Top players like 3M, Henry Schein, and Align Technology innovate using clear aligners and AI, fosteri

Align Technology reported Q3 earnings beating analyst expectations, with sales growing less than 2% year-over-year. Despite a stock price increase, the company's earnings and free cash flow are declining, suggesting potential challenges.

Align Technology reported record Invisalign case submissions in Q4 with 87.7 thousand doctors submitting cases. Revenue beat expectations at $1.048 billion (+5.3% YoY) and adjusted EPS of $3.29 surpassed consensus of $2.97. The company projects 3-4% revenue growth for fiscal 2026 with improving margins, sending shares up 10.43% in premarket trading.